跳到主要内容

UTAH MEDICAL PRODUCTS INC (UTMD) Stock Forecast 2025 - AI Price Prediction & Analysis


UTAH MEDICAL PRODUCTS INC (UTMD) AI Stock Price Forecast & Investment Analysis

UTAH MEDICAL PRODUCTS INC Stock Price Chart and Technical Analysis

Loading UTAH MEDICAL PRODUCTS INC interactive price chart and technical analysis...

UTAH MEDICAL PRODUCTS INC (UTMD) - Comprehensive Stock Analysis & Investment Research

Deep dive into UTAH MEDICAL PRODUCTS INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about UTAH MEDICAL PRODUCTS INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For UTAH MEDICAL PRODUCTS INC: UTAH MEDICAL PRODUCTS INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

UTAH MEDICAL PRODUCTS INC (Stock Symbol: UTMD) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 48 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing UTAH MEDICAL PRODUCTS INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For UTAH MEDICAL PRODUCTS INC: With $38M in annual revenue and 30.4% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $38 million generating a 30.4% net profit margin .

Market Capitalization: $208 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 14.3% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for UTAH MEDICAL PRODUCTS INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For UTAH MEDICAL PRODUCTS INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for UTAH MEDICAL PRODUCTS INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: UTAH MEDICAL PRODUCTS INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For UTAH MEDICAL PRODUCTS INC: Strong free cash flow generation demonstrates developing operational efficiency.

UTAH MEDICAL PRODUCTS INC strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $20 million annually, complemented by impressive 18.1% year-over-year cash flow growth.

The company maintains a healthy 62.5% gross margin, indicating strong pricing power and operational efficiency.

UTAH MEDICAL PRODUCTS INC (UTMD) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for UTAH MEDICAL PRODUCTS INC stock analysis.

Loading UTAH MEDICAL PRODUCTS INC comprehensive fundamental analysis and insider trading data...

Deep dive into UTAH MEDICAL PRODUCTS INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if UTAH MEDICAL PRODUCTS INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For UTAH MEDICAL PRODUCTS INC: With a P/E ratio of 16.55, the market moderately values the company's earnings.

P/E Ratio 16.55x
P/B Ratio 1.77x
Market Cap $208M
Dividend Yield 0.01%
EPS $3.75
Book Value/Share $35.86
Revenue/Share $11.84
FCF/Share $5.12
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently UTAH MEDICAL PRODUCTS INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For UTAH MEDICAL PRODUCTS INC: An ROE of 14.3% shows good shareholder value creation.

ROE 14.3%
ROA 13.1%
ROIC 14.3%
Gross Margin 62.5%
Operating Margin 38.7%
Net Margin 30.4%
EBT Margin 39.1%
Tax Rate 22.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess UTAH MEDICAL PRODUCTS INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For UTAH MEDICAL PRODUCTS INC: A current ratio of 13.03 indicates strong liquidity.

Current Ratio 13.03x
Quick Ratio 11.74x
D/E Ratio 0.02x
Financial Leverage 1.10x
Interest Coverage 240.2x
Working Capital $58M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal UTAH MEDICAL PRODUCTS INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For UTAH MEDICAL PRODUCTS INC: Free cash flow of $20M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $21M
Free Cash Flow $20M
Capital Spending $-1M
OCF Growth YoY 18.1%
FCF Growth YoY 7.3%
FCF/Sales 39.6%
CapEx/Sales 1.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively UTAH MEDICAL PRODUCTS INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For UTAH MEDICAL PRODUCTS INC: An asset turnover of 0.43x suggests room for improvement in asset utilization.

Asset Turnover 0.43x
Receivables Turnover 10.2x
Inventory Turnover 2.8x
Fixed Assets Turnover 4.6x
Days Sales Outstanding 36 days
Days Inventory 129 days
Payables Period 22 days
Cash Conversion Cycle 142 days
Understanding Financial Statement Data

What these metrics mean: Key figures from UTAH MEDICAL PRODUCTS INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For UTAH MEDICAL PRODUCTS INC: With annual revenue of $38M, UTAH MEDICAL PRODUCTS INC represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $38M
R&D Expense $1M
SG&A Expense $23M
Cost of Goods Sold $18M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 66%
Cash & Short-term Investments 55%
Total Liabilities 9%
Short-term Debt 5%
Accounts Receivable 5%
Inventory 6%
Dividend & Shareholder Information
Dividends Per Share $0.90
Payout Ratio 0.3%
Shares Outstanding 3M
Growth Metrics (YoY)
EPS Growth 7.1%

Latest UTAH MEDICAL PRODUCTS INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting UTAH MEDICAL PRODUCTS INC (UTMD) stock price and investment outlook.

, source: Morningstar

SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ...

, source: Barron's

About Utah Medical Products Inc. Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women ...

UTAH MEDICAL PRODUCTS INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of UTAH MEDICAL PRODUCTS INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $24M x 2.8x
AEMD Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.7x
AFIB Unlock Forecast - 30 Days FREE Trial $0M 0.0x -0.4x
ALUR Unlock Forecast - 30 Days FREE Trial $17M -0.4x -0.3x
AMIX Unlock Forecast - 30 Days FREE Trial $4M x 0.5x
ANGO Unlock Forecast - 30 Days FREE Trial $447M -1.4x 2.4x
ANIK Unlock Forecast - 30 Days FREE Trial $129M -4.3x 0.9x
AORT Unlock Forecast - 30 Days FREE Trial $1858M -198.2x 4.4x
APYX Unlock Forecast - 30 Days FREE Trial $76M -3.5x 10.5x
ARAY Unlock Forecast - 30 Days FREE Trial $138M -9.9x 2.8x
ATEC Unlock Forecast - 30 Days FREE Trial $2301M -7.4x 96.8x
ATRC Unlock Forecast - 30 Days FREE Trial $1811M -39.6x 3.9x
AVGR Unlock Forecast - 30 Days FREE Trial $2M -1.3x 0.4x
AVHHL Unlock Forecast - 30 Days FREE Trial $24M x x
BAX Unlock Forecast - 30 Days FREE Trial $12280M -94.9x 1.7x
BBNX Unlock Forecast - 30 Days FREE Trial $1101M x 3.7x
BDX Unlock Forecast - 30 Days FREE Trial $55013M 34.7x 2.2x
BEAT Unlock Forecast - 30 Days FREE Trial $46M -5.7x 11.0x
BEATW Unlock Forecast - 30 Days FREE Trial $15M x 3.2x
BJDX Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.4x
BLAC Unlock Forecast - 30 Days FREE Trial $12M x -2.1x
BLACR Unlock Forecast - 30 Days FREE Trial $1M x -0.2x
BLACU Unlock Forecast - 30 Days FREE Trial $14M x -2.4x
BLACW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BSX Unlock Forecast - 30 Days FREE Trial $155811M 62.2x 7.0x
BTCY Unlock Forecast - 30 Days FREE Trial $10M -2.7x -0.1x
BVS Unlock Forecast - 30 Days FREE Trial $617M -18.3x 3.8x
CARL Unlock Forecast - 30 Days FREE Trial $-18M x x
CERS Unlock Forecast - 30 Days FREE Trial $235M -13.8x 4.2x
CLPT Unlock Forecast - 30 Days FREE Trial $314M -23.5x 15.9x
CODX Unlock Forecast - 30 Days FREE Trial $11M -0.7x 0.3x
CTCX Unlock Forecast - 30 Days FREE Trial $5M -0.2x -1.2x
CTCXW Unlock Forecast - 30 Days FREE Trial $1M x -0.2x
CTSO Unlock Forecast - 30 Days FREE Trial $64M -1.8x 4.4x
CVRX Unlock Forecast - 30 Days FREE Trial $208M -5.5x 3.6x
DCTH Unlock Forecast - 30 Days FREE Trial $465M 208.2x 4.4x
DHAI Unlock Forecast - 30 Days FREE Trial $10M x -0.3x
DHAIW Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
DRIO Unlock Forecast - 30 Days FREE Trial $30M 0.6x 0.4x
DRTS Unlock Forecast - 30 Days FREE Trial $306M x 3.5x
DXCM Unlock Forecast - 30 Days FREE Trial $30993M 54.2x 12.0x
EBRCZ Unlock Forecast - 30 Days FREE Trial $246M x 5.0x
EMBC Unlock Forecast - 30 Days FREE Trial $572M 15.8x -0.8x
FEMY Unlock Forecast - 30 Days FREE Trial $12M -1.4x 8.1x
FNA Unlock Forecast - 30 Days FREE Trial $1098M -15.4x 8.4x
FOFA Unlock Forecast - 30 Days FREE Trial $8M x 13.6x
GCTK Unlock Forecast - 30 Days FREE Trial $2M 0.9x -0.5x
GIPL Unlock Forecast - 30 Days FREE Trial $5M x 27.9x
GKOS Unlock Forecast - 30 Days FREE Trial $5010M -46.3x 6.6x
GMED Unlock Forecast - 30 Days FREE Trial $8073M 22.6x 1.9x
GUTS Unlock Forecast - 30 Days FREE Trial $88M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $3541M 26.1x 4.3x
HRGN Unlock Forecast - 30 Days FREE Trial $28M x 36.7x
IART Unlock Forecast - 30 Days FREE Trial $1185M 200.2x 1.1x
ICAD Unlock Forecast - 30 Days FREE Trial $106M -3.1x 3.5x
ICCM Unlock Forecast - 30 Days FREE Trial $60M x 20.9x
ICU Unlock Forecast - 30 Days FREE Trial $8M -1.1x 13.3x
ICUCW Unlock Forecast - 30 Days FREE Trial $0M x -0.1x
ICUI Unlock Forecast - 30 Days FREE Trial $3248M -49.8x 1.6x
IDXG Unlock Forecast - 30 Days FREE Trial $22M 4.2x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $30M x 6.8x
IINNW Unlock Forecast - 30 Days FREE Trial $8M x 2.0x
INBS Unlock Forecast - 30 Days FREE Trial $11M -0.3x 3.6x
INFU Unlock Forecast - 30 Days FREE Trial $216M 42.6x 4.0x
INSP Unlock Forecast - 30 Days FREE Trial $2395M 45.1x 3.5x
IRMD Unlock Forecast - 30 Days FREE Trial $953M 46.1x 10.1x
IRTC Unlock Forecast - 30 Days FREE Trial $5845M -20.2x 56.4x
IVF Unlock Forecast - 30 Days FREE Trial $1M x 0.3x
KIDS Unlock Forecast - 30 Days FREE Trial $488M -20.7x 1.4x
KMTS Unlock Forecast - 30 Days FREE Trial $873M x x
KRMD Unlock Forecast - 30 Days FREE Trial $188M -19.8x 11.4x
LMAT Unlock Forecast - 30 Days FREE Trial $0M 58.7x 0.0x
LNSR Unlock Forecast - 30 Days FREE Trial $58M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $140M -0.6x 17.7x
LUNG Unlock Forecast - 30 Days FREE Trial $71M -4.3x 1.0x
LYRA Unlock Forecast - 30 Days FREE Trial $524M -0.1x 135.2x
MBOT Unlock Forecast - 30 Days FREE Trial $92M -1.3x 3.2x
MCAG Unlock Forecast - 30 Days FREE Trial $22M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $21M x -9.9x
MDAI Unlock Forecast - 30 Days FREE Trial $69M -1.3x -42.3x
MDAIW Unlock Forecast - 30 Days FREE Trial $9M x -2.1x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.8x 13.4x
MDXG Unlock Forecast - 30 Days FREE Trial $1068M 33.2x 4.9x
MGRM Unlock Forecast - 30 Days FREE Trial $206M -10.7x 23.9x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $88018M 22.3x 20.5x
MMSI Unlock Forecast - 30 Days FREE Trial $5411M 45.4x 3.6x
MODD Unlock Forecast - 30 Days FREE Trial $38M -2.1x 2.2x
NARI Unlock Forecast - 30 Days FREE Trial $4677M -51.9x 10.8x
NAYA Unlock Forecast - 30 Days FREE Trial $2M -0.3x 0.2x
NEPH Unlock Forecast - 30 Days FREE Trial $39M -20.3x 2.0x
NMTC Unlock Forecast - 30 Days FREE Trial $40M -1.7x 4.8x
NPCE Unlock Forecast - 30 Days FREE Trial $322M -10.4x 16.5x
NSPR Unlock Forecast - 30 Days FREE Trial $122M -4.3x 6.0x
NURO Unlock Forecast - 30 Days FREE Trial $9M -0.5x 0.7x
NVAC Unlock Forecast - 30 Days FREE Trial $69M 84.3x -13.6x
NVACR Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
NVACW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
NVCR Unlock Forecast - 30 Days FREE Trial $1423M -20.8x 4.1x
NVNO Unlock Forecast - 30 Days FREE Trial $87M -2.0x 2.3x
NVRO Unlock Forecast - 30 Days FREE Trial $221M -2.1x 1.0x
NXGL Unlock Forecast - 30 Days FREE Trial $18M -6.8x 4.0x
NXGLW Unlock Forecast - 30 Days FREE Trial $3M x 0.7x
OBIO Unlock Forecast - 30 Days FREE Trial $118M -3.4x 2.0x
OFIX Unlock Forecast - 30 Days FREE Trial $580M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $18M x 0.2x
OSUR Unlock Forecast - 30 Days FREE Trial $241M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $20M 0.3x 0.5x
PAVMZ Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
PDEX Unlock Forecast - 30 Days FREE Trial $128M 14.3x 3.5x
PEN Unlock Forecast - 30 Days FREE Trial $10665M 72.2x 8.2x
PETV Unlock Forecast - 30 Days FREE Trial $18M -1.4x 12.0x
PLSE Unlock Forecast - 30 Days FREE Trial $1016M -2.6x 8.6x
PODD Unlock Forecast - 30 Days FREE Trial $23872M 101.1x 16.3x
PRCT Unlock Forecast - 30 Days FREE Trial $2178M -45.4x 5.7x
PROF Unlock Forecast - 30 Days FREE Trial $124M x 3.2x
PSTV Unlock Forecast - 30 Days FREE Trial $12M -0.3x -0.5x
PYPD Unlock Forecast - 30 Days FREE Trial $54M x 2.6x
RCEL Unlock Forecast - 30 Days FREE Trial $111M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $47M x 17.4x
RMD Unlock Forecast - 30 Days FREE Trial $40461M 28.9x 6.8x
RSMDF Unlock Forecast - 30 Days FREE Trial $2450M 1.8x 0.4x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $24M -0.9x 0.3x
SGHT Unlock Forecast - 30 Days FREE Trial $192M -3.7x 2.7x
SIBN Unlock Forecast - 30 Days FREE Trial $701M -14.3x 4.1x
SINT Unlock Forecast - 30 Days FREE Trial $7M -0.5x 1.1x
SKIN Unlock Forecast - 30 Days FREE Trial $288M -1.8x 3.9x
SNOA Unlock Forecast - 30 Days FREE Trial $8M -5.6x 1.9x
SNWV Unlock Forecast - 30 Days FREE Trial $308M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12464M 32.8x 3.4x
SRDX Unlock Forecast - 30 Days FREE Trial $432M -79.3x 3.9x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSII Unlock Forecast - 30 Days FREE Trial $1535M x 37.9x
SSKN Unlock Forecast - 30 Days FREE Trial $7M -8.0x 24.1x
STIM Unlock Forecast - 30 Days FREE Trial $248M -1.0x 9.1x
STME Unlock Forecast - 30 Days FREE Trial $12M x x
STSS Unlock Forecast - 30 Days FREE Trial $10M -2.5x 0.7x
STSSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SYK Unlock Forecast - 30 Days FREE Trial $140684M 42.0x 12.0x
TCMD Unlock Forecast - 30 Days FREE Trial $319M 21.1x 1.6x
TELA Unlock Forecast - 30 Days FREE Trial $72M -1.8x 7.9x
TFX Unlock Forecast - 30 Days FREE Trial $5879M 30.6x 1.4x
TLSI Unlock Forecast - 30 Days FREE Trial $191M -3.6x -5.6x
TLSIW Unlock Forecast - 30 Days FREE Trial $66M x -1.9x
TMCI Unlock Forecast - 30 Days FREE Trial $628M -7.5x 6.0x
TNDM Unlock Forecast - 30 Days FREE Trial $864M -17.1x 6.5x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.3x
TNONW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
TTOO Unlock Forecast - 30 Days FREE Trial $4M 0.0x -0.3x
UFPT Unlock Forecast - 30 Days FREE Trial $1757M 44.7x 4.9x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $208M 16.6x 1.8x
VERO Unlock Forecast - 30 Days FREE Trial $5M 0.0x 2.2x
VTAK Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.3x
VVOS Unlock Forecast - 30 Days FREE Trial $21M -0.5x 2.8x
WST Unlock Forecast - 30 Days FREE Trial $19200M 39.4x 6.6x
XAIR Unlock Forecast - 30 Days FREE Trial $303M -0.3x 22.3x
XTNT Unlock Forecast - 30 Days FREE Trial $93M -478.8x 1.9x

Frequently Asked Questions - UTAH MEDICAL PRODUCTS INC Stock Forecast

How accurate are UTAH MEDICAL PRODUCTS INC stock predictions?

Our AI model demonstrates 67% historical accuracy for UTMD predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence UTAH MEDICAL PRODUCTS INC stock price forecasts?

Our analysis considers UTAH MEDICAL PRODUCTS INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is UTAH MEDICAL PRODUCTS INC a good investment in 2025?

Based on our AI analysis, UTAH MEDICAL PRODUCTS INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are UTAH MEDICAL PRODUCTS INC forecasts updated?

UTAH MEDICAL PRODUCTS INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced UTAH MEDICAL PRODUCTS INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for UTAH MEDICAL PRODUCTS INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...